A Second Pedigree with Autosomal Dominant Nemaline Myopathy Caused by TPM3 Mutation: a Clinical and Pathological Study
Overview
Affiliations
The slow alpha-tropomyosin (TPM3) gene has to date been associated with few cases of both dominant and recessive nemaline myopathies. We report the identification of a p.Arg167His mutation in a four-generation family presenting with a mild classical form of the disease. Clinically, there was no correlation between the age at presentation and the severity of the disease. The dominant-negative p.Arg167His mutation is a recurrent mutation, previously reported in one sporadic case. Histological studies showed discrepancy between the two reports. While a type II fibre predominance was described in the sporadic case, we observed an almost complete type I fibre predominance. This study emphasizes the variability in histopathological phenotypes seen with TPM3 mutations.
Tropomyosin 3 (TPM3) function in skeletal muscle and in myopathy.
Lambert M, Gussoni E Skelet Muscle. 2023; 13(1):18.
PMID: 37936227 PMC: 10629095. DOI: 10.1186/s13395-023-00327-x.
Chen Z, Saini M, Koh J, Lim G, Dang N, Prasad K BMC Neurol. 2023; 23(1):181.
PMID: 37147571 PMC: 10161565. DOI: 10.1186/s12883-023-03225-3.
Yuen M, Cooper S, Marston S, Nowak K, McNamara E, Mokbel N Hum Mol Genet. 2015; 24(22):6278-92.
PMID: 26307083 PMC: 4614700. DOI: 10.1093/hmg/ddv334.
Marttila M, Lehtokari V, Marston S, Nyman T, Barnerias C, Beggs A Hum Mutat. 2014; 35(7):779-90.
PMID: 24692096 PMC: 4200603. DOI: 10.1002/humu.22554.
Myofilament lattice structure in presence of a skeletal myopathy-related tropomyosin mutation.
Ochala J, Iwamoto H J Muscle Res Cell Motil. 2013; 34(3-4):171-5.
PMID: 23686574 DOI: 10.1007/s10974-013-9345-x.